F

Franchise Global Health Inc
XTSX:FGH

Watchlist Manager
Franchise Global Health Inc
XTSX:FGH
Watchlist
Price: 0.015 CAD Market Closed
Market Cap: 60.5m CAD

Profitability Summary

Franchise Global Health Inc's profitability score is 36/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

36/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

36/100
Profitability
Score
36/100
Profitability
Score

Margins

Earnings Waterfall
Franchise Global Health Inc

Margins Comparison
Franchise Global Health Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CA
Franchise Global Health Inc
XTSX:FGH
60.5m CAD
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
519.1B USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
380.6B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
274.5B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219.7B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
206.8B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
277.1B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Franchise Global Health Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CA
Franchise Global Health Inc
XTSX:FGH
60.5m CAD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
519.1B USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
380.6B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
274.5B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219.7B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
206.8B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
277.1B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Franchise Global Health Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate